← TickerEye

0JDM.LIQVIA Holdings Inc.

Acción·LSE·£

£203,41+5.93%
...
Máximo del día£206,08
Mínimo del día£194,22
Volumen1.52K

Acerca de

IQVIA Holdings Inc. is a global leader empowering the life sciences sector with advanced analytics, innovative technology solutions, and comprehensive clinical research services. Operating across the Americas, Europe, Africa, and the Asia-Pacific regions, its capabilities are organized into three main divisions. Within its Technology & Analytics Solutions segment, IQVIA delivers cloud-based applications alongside essential implementation services. It also specializes in real-world solutions, enabling clients to generate and disseminate crucial evidence that informs healthcare decisions and ultimately enhances patient outcomes. This segment extends its expertise to strategic and implementation consulting, encompassing advanced analytics and commercial process outsourcing. Furthermore, it furnishes comprehensive market performance data, tracking pharmaceutical sales, prescribing trends, treatment efficacy, and promotional activities at a granular level – from country-wide views down to regional, zip code, and individual prescriber insights, across diverse channels like retail, hospital, and mail order. The Research & Development Solutions segment offers a broad spectrum of support for clinical trials, from initial strategic planning and design to meticulous project management and clinical monitoring, including innovative virtual trial capabilities. Complementing these, it provides an extensive array of laboratory services, such as central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment focuses on engaging healthcare providers and patients, alongside offering scientific strategy and medical affairs support. IQVIA's client base spans pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. Additionally, the firm maintains a strategic alliance with HealthCore, Inc. Founded in 1982, the company was initially known as Quintiles IMS Holdings, Inc., before rebranding as IQVIA Holdings Inc. in November 2017. Its corporate headquarters are situated in Durham, North Carolina.

www.iqvia.com

Estadísticas clave

Cap. de mercado
34.60B
BPA
7.92
Rend. dividendo
0.00%
Beta
1.22
P/VC
6.01
ROE
20.9%
Sector
Healthcare
Industria
Medical - Diagnostics & Research
CEO
Ari Bousbib
Empleados
89.000
Fecha IPO
2018-01-29
País
US

Sigue en vivo con TickerEye

Ve el precio de 0JDM.L en vivo en tu pantalla física de escritorio. Configura alertas con las apps iOS y Android.